US Patent 11254672 Dihydrobenzimidazolones for medical treatment
Patent 11254672 was granted and assigned to C4 Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11254672 Dihydrobenzimidazolones for medical treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.